Cannabis for Therapeutic Purposes and public health and safety: A systematic and critical review

Sznitman, Sharon R.; Zolotov, Yuval

doi:10.1016/j.drugpo.2014.09.005

Cited by 43 publications

(34 citation statements)

References 55 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some States in the US have shifted their policy stance to permit use of cannabis for therapeutic purposes (CTP) (Chu, 2014). This legalisation in the form of de facto supply for medical use has not caused increased consumption, prevalence of use or related adverse consequences (Nussbaum, Boyer & Kondrad, 2011;Hall & Weier, 2015;Sznitman and Zolotov, 2015;Ziemianski, Capler, Tekanoff , Lacasse, Luconi & Ware, 2015) and according to one study has contributed to heightened patient perceptions of safety and awareness (Trout & DiDonato, 2015). (Ebert, Zolotov, Eliav, Ginzburg, Shapira & Magnezi, 2015), with Israeli rheumatologists observing a majority opinion for the role of cannabinoids in the management of rheumatoid disease (Ablin, Elkayam & Fitzcharles, 2016).…”

mentioning

confidence: 99%

Irish General Practitioner (GP) Perspectives Toward Decriminalisation, Legalisation and Cannabis for Therapeutic Purposes (CTP)

Hout

Collins²,

Delargy³

et al. 2016

Int J Ment Health Addiction

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Irish General Practitioner (GP) Perspectives Toward Decriminalisation, Legalisation and Cannabis for Therapeutic Purposes (CTP)

Hout

Collins²,

Delargy³

et al. 2016

Int J Ment Health Addiction

View full text Add to dashboard Cite

show abstract

“…For example, while the minimum age for use in Colorado and Washington is 21 years, it is set at 18 years in Uruguay (5). Despite these guidelines, there are significant concerns that legalising a substance that was criminalised on the basis of its harmfulness may reduce young of its harm, reduce its cost and hence increase access or use (4,13,(16)(17)(18). Preventing the uptake of cannabis is critical because it is much easier to prevent initiation than to encourage users to quit during a period of their lives when they are more vulnerable to health related harm (19).…”

Section: Protection Of Young Peoplementioning

confidence: 99%

“…Cannabis for medicinal use has been legalised in 23 states in the USA, Canada, Netherlands and Israel amidst widening debates in other countries (13). The majority of cannabis users worldwide, however, live within areas where cannabis use is still considered illegal (14).…”

Section: Changes In the Legal Status Of Cannabis Usementioning

confidence: 99%

Influence of legal status on the uptake of cannabis in young people

Dirisu

Shickle²,

Elsey³

2016

Current Opinion in Psychiatry

View full text Add to dashboard Cite

Recent findings:There are significant concerns that ongoing policy changes in favour of legalisation will increase the uptake of cannabis by young people. Evidence to support a causal effect of cannabis policy changes on increased uptake by young people is lacking; more time may be needed to assess the impact because the policies are still evolving. Policy changes in favour of legalisation were associated with reduced risk perception although this may be a cause or consequence. The need to situate the impact of these policies in the context of specific policy features, social norms and perceptions about cannabis has been highlighted. Summary:A more nuanced understanding of the impact of the legal status of cannabis on young people is needed to build evidence for future policy options. The impact of these policies may not be immediately apparent but l prioritised during policy deliberations.

show abstract

“…At the federal level, the Obama Administration has instructed prosecutors and law enforcement officials not to focus on individuals "whose actions are unclear and unambiguous compliance with existing state laws providing for the medical use of medical marijuana". Thus, the shift in federal position prompted a drastic increase in registration for medical marijuana, particularly in Colorado [40][41][42][43][44].…”

Section: Cost For Marijuana?mentioning

confidence: 99%

Health Policy for Marijuana

Miller¹,

Oberbarnscheidt²

2017

J Addict Res Ther

View full text Add to dashboard Cite

Marijuana is a substance that has been used for recreational purposes since ancient years and that is currently discussed to have a therapeutic or medical value and to be seen as a Medicine.According to the FDA, marijuana is classified as a Schedule I drug with high risk of addiction and no medical benefit. However, it is legal in several states for deliberating conditions e.g. various pain conditions, depression, anxiety, nail patella, glaucoma and even HIV.In addition people use is for various other conditions even though studies have shown greater harmful effects then benefit. Especially with marijuana, there is a high rate of misperception in the users. In addition, marijuana has a unique pharmacology and pharmacodynamics because of its more than 400 partially unknown components and the storage in the user's lipophilic tissues and redistribution long after the last use.The legalization of marijuana is already done in some states and other states are pressured to follow along.This article is a systematic review of literature analyzing the current policies, legal situations and trend as well as politics regarding marijuana and its use. The article is focused on the natural form of the Cannabis sativa plant.

show abstract

Cannabis for Therapeutic Purposes and public health and safety: A systematic and critical review

Cited by 43 publications

References 55 publications

Irish General Practitioner (GP) Perspectives Toward Decriminalisation, Legalisation and Cannabis for Therapeutic Purposes (CTP)

Irish General Practitioner (GP) Perspectives Toward Decriminalisation, Legalisation and Cannabis for Therapeutic Purposes (CTP)

Influence of legal status on the uptake of cannabis in young people

Health Policy for Marijuana

Contact Info

Product

Resources

About